3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
2
Uveal Melanoma
1
Neuroendocrine Tumors
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Immunoblastic Lymphadenopathy
1
Eye Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Neuroendocrine
1
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
12
Cisplatin
9
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
pembrolizumab
6
Radiotherapy, Intensity-Modulated
6
Cetuximab
6
Biopsy
6
Radiation
5
Carboplatin
5
Radiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
X-Rays
3
Taxes
3
Standard of Care
3
Paclitaxel
3
Immunoglobulin G
3
Disulfides
3
ipatasertib
2
Ultrasonography
2
Practice Guidelines as Topic
2
Nivolumab
2
Interviews as Topic
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Docetaxel
2
Bevacizumab
2
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
belinostat
×
90 days
×
Clear all
No trials found.